Hervana Bio ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Developing probiotic-based therapies as non-hormonal contraceptives with added STI protection.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2008
Last updated 2026-07-20
Total raised
$1.1M
Last: Grant 2012-12
Stage
Pre-Funding
Founded
2008
Headcount
3
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Hervana Bio is a biopharmaceutical company focused on developing innovative products in women's health. Their primary product is a non-hormonal female contraceptive platform technology, built on probiotic Lactobacilli, which offers unique benefits including added protection against sexually transmitted infections (STIs). Their candidate, LJ-102, is designed to be administered to the female reproductive tract, interfering with fertilization and promoting STD resistance.

Funding history · 2 rounds · $1.1M total

2012-11
Grant $1.0M
2010-04
Grant $100K

Headcount over time

From 1 (2019-03) to 2 (2023-12) · +1 (+100%) · 4 points · source: Finder history + radar grounding
40 2019-03 2023-12

Q&A

What is Hervana Bio's primary focus?
Hervana Bio is a biopharmaceutical company that develops women's health products, specifically a non-hormonal female contraceptive technology that also offers protection against sexually transmitted infections.
When was Hervana Bio founded?
Hervana Bio was founded in June 2008.
How many employees does Hervana Bio have?
Hervana Bio has 1-10 employees.
What is the total amount of funding Hervana Bio has raised?
Hervana Bio has raised a total of $1,100,000.
Which organization has provided grant funding to Hervana Bio?
The Bill & Melinda Gates Foundation has provided grant funding to Hervana Bio.
When did Hervana Bio receive its most recent grant funding?
Hervana Bio received a $1,000,000 grant in December 2012 from the Bill & Melinda Gates Foundation.
What is the current product stage of Hervana Bio's technology?
Hervana Bio's product is currently in the clinical trial stage.
Who is the Founder and CEO of Hervana Bio?
Rachel Teitelbaum, PhD is the Founder and CEO of Hervana Bio.

Team · 1

Rachel Teitelbaum
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 Patents

Tags

pregnancybiotechnologywomen-healthpharmaceuticalswomenfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitehervana-bio.com
LinkedInlinkedin.com/company/2090562

Identifiers & details

Founded2008-6
Employees (exact)3

Radar intelligence

Web history (Wayback)

Domainhervana-bio.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514154038
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2008-06-24
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressנפתלי 9 ירושלים